Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Wilkinson

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|September 1, 1990
Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicinH H Zhou, L B Anthony, A J Wood, et al.
British Journal of Clinical Pharmacology|November 1, 1990
Frequency of impaired mephenytoin 4'-hydroxylation in an Indian populationB S Doshi, R D Kulkarni, B L Chauhan, et al.
Molecular Pharmacology|May 1, 1992
Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4C M Fleming, R A Branch, G R Wilkinson, et al.
Pharmacogenetics|January 14, 2000
Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genesP Dalén, M L Dahl, M Eichelbaum, et al.
The Journal of Clinical Investigation|February 1, 1975
The effects of age and liver disease on the disposition and elimination of diazepam in adult manU Klotz, G R Avant, A Hoyumpa, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockadeT C Raghuram, R P Koshakji, G R Wilkinson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1987
Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in manP J Wedlund, B J Sweetman, G R Wilkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomesS D Hall, F P Guengerich, R A Branch, et al.
The American Journal of Cardiology|August 29, 1986
Disposition kinetics of encainide and metabolitesD M Roden, A J Wood, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1997
Dietary salt increases first-pass elimination of oral quinidineD Darbar, S Dell'Orto, K Mörike, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|September 1, 1990
Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicinH H Zhou, L B Anthony, A J Wood, et al.
British Journal of Clinical Pharmacology|November 1, 1990
Frequency of impaired mephenytoin 4'-hydroxylation in an Indian populationB S Doshi, R D Kulkarni, B L Chauhan, et al.
Molecular Pharmacology|May 1, 1992
Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4C M Fleming, R A Branch, G R Wilkinson, et al.
Pharmacogenetics|January 14, 2000
Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genesP Dalén, M L Dahl, M Eichelbaum, et al.
The Journal of Clinical Investigation|February 1, 1975
The effects of age and liver disease on the disposition and elimination of diazepam in adult manU Klotz, G R Avant, A Hoyumpa, et al.
Clinical Pharmacology and Therapeutics|July 1, 1984
Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockadeT C Raghuram, R P Koshakji, G R Wilkinson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1987
Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in manP J Wedlund, B J Sweetman, G R Wilkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomesS D Hall, F P Guengerich, R A Branch, et al.
The American Journal of Cardiology|August 29, 1986
Disposition kinetics of encainide and metabolitesD M Roden, A J Wood, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1997
Dietary salt increases first-pass elimination of oral quinidineD Darbar, S Dell'Orto, K Mörike, et al.
Pageof 19